Trump To Sign Executive Order On Essential Medicines

Today, President Trump will sign an executive order on trade and manufacturing of pharmaceutical products. Ava DeSantis writes about what you should know about the upcoming order.


 

Photo by Shealah Craighead

A senior administration official spoke to the press at a briefing this morning concerning the executive order. “It is a great day for America,” the official began, “the President promised that he would bring the change in production for our essential medicine. Today, we are taking a very big step towards fulfillment of that promise.”

A ‘pure Trump’ order

During his 2016 campaign, Trump railed against drug companies pricing products unreasonably. In a cover story for Time Magazine, Trump said “I don’t like what has happened with drug prices.” He accused pharmaceutical industry leaders of lobbying politicians to their advantage, saying in a GOP primary debate “they have a fantastic lobby. They take care of all the senators, the congressmen.” 

When Trump won the 2016 election, John Rother, executive director of the Campaign for Sustainable Rx Pricing, said “tuesday’s election results are a clear indication that people around the country want change, and one issue that came up again and again on the campaign trail is that Americans are tired of skyrocketing drug prices.”

Today’s executive order will “ensure essential medicines, countermeasures, and critical inputs are made in the United States,” the official explained. “If we’ve learned anything from the China virus pandemic, it is simply that we’re dangerously overdependent on our nation.” The administration official described essential medicines and supplies as “ventilators and the like,” indicating that the order may focus on COVID-19 specific medicines and supplies.

The administration believes pharmaceutical drugs produced overseas have overtaken American markets because of lower health, labor, and tax standards which make production cheaper. “The problem is simply that across the world we have sweatshop labeling,” explained the official. “We have pollution havens.” India, for example, has “an unfair competitive advantage” because of their “lack of regulatory environment.” 

The order is a “pure Trump” solution. It will have three major components: a “bi-American component,” a “regulation” component, and a third component which will introduce “continuous manufacturing.”

The bi-American component will require that American agencies, like the Veterans Affairs Agency, are the largest procurers of medicines and medical countermeasures. 

The regulation component will address uneven standards for production abroad and at home. According to the official, “we have a situation where both the FDA and the EPA” can walk into an American factory and inspect it, but does not have jurisdiction in “China or India.” This discrepancy allows pharmaceutical companies in these countries to “get away with” health and safety violations. To accomplish this, the administration will “streamline” the American regulatory process.

The third component will introduce “continuous manufacturing” in the US, allowing manufacturers to “do two or all three stages in the production process” at a single site.

Foreign dependence

“We are dangerously dependent,” the Trump administration official claimed. According to Janet Woodstock, director of the FDA’s Center for Drug Evaluation and Research, 72% of pharmaceutical manufacturers of products in American markets are located overseas. 13% of these manufacturers are located in China. The administration is distrustful of foreign involvement in American medicine and health policy. The official casually referred to the World Health Organization as “the colony of China,” during today’s briefing.

Last month, President Trump signed a series of executive orders similarly aimed at curbing foreign pharmaceutical production. On July 24th alone, Trump signed four executive orders to even the cost of foreign and domestic pharmaceuticals. “Under my administration,” Trump said at the signing, “we’re standing up to lobbyists and special interests and fighting back against a rigged system.”

 

Comments

Find us at

Twitter RSS Flipboard

Share This Article!

Like this article?

Tags

Pharmaceuticals drug pricing Donald Trump World Health Organization COVID-19 Coronavirus

Related stories

Jen Psaki Reiterates That Biden Has Never Supported Defunding The Police

Jen Psaki Reiterates That Biden Has Never Supported Defunding The Police

1. Biden’s vision for crime and police Ahead of Biden’s remarks on crime tomorrow, Psaki spoke on the administration’s vision for crime prevention and police reform in America. She specifically mentioned the increase…

Read more trending_flat
4 Key Takeaways From Monday’s Press Briefing At The White House

4 Key Takeaways From Monday’s Press Briefing At The White House

1. Voting Rights Act Set to Fail Talk about the filibuster continues, as an expansive voting rights bill heads to a Senate vote later this week. The For the People Act would overhaul federal voting legislation. It’s largely…

Read more trending_flat
News At 9 PM: From Trump’s Endorsement Of Tshibaka To UN Intervention In Myanmar

News At 9 PM: From Trump’s Endorsement Of Tshibaka To UN Intervention In Myanmar

Former President Trump Endorses Tshibaka Over Murkowski in Alaska Former President Donald Trump has stated his endorsement for Kelly Tshibaka over Republican Senator Lisa Murkowski for the Alaska Senate race. On Friday, he pledged…

Read more trending_flat
News At 9 PM: From A New Covid Pill To Ending The Iraq War Resolution 

News At 9 PM: From A New Covid Pill To Ending The Iraq War Resolution 

1. Supreme Court Rules in Favor of Obamacare The US Supreme Court ruled to uphold the Affordable Care Act, or Obamacare, on Thursday despite many conservative states resisting the Act and deeming it unconstitutional. The vote was…

Read more trending_flat
“The Promise of Equality” Comes As President Biden Signs Legislation Making Juneteenth A Federal Holiday

“The Promise of Equality” Comes As President Biden Signs Legislation Making Juneteenth A Federal Holiday

On June 17, 2021, President Biden signed into law the “Juneteenth National Independence Day Act,” which designates Juneteenth National Independence Day as a legal public holiday. The holiday is the first created by Congress…

Read more trending_flat
News at 9PM: From Biden-Putin Summit To Juneteenth, New Federal Holiday

News at 9PM: From Biden-Putin Summit To Juneteenth, New Federal Holiday

1. Biden and Putin Issue Joint Statement  On Wednesday, President Biden had a 3-hour summit with Russian President Putin for the first time since getting elected in 2020. In the meeting, the two political leaders discussed…

Read more trending_flat

Latest article

Top